Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in ...
On April 20, 2004, Elaine was diagnosed with Ph+ acute lymphoblastic leukaemia (Ph+ ALL). ALL is an aggressive blood cancer ...
When Elaine Bolton, then 35, received her leukaemia diagnosis, a nurse told her that she would have died within two weeks had ...
If approved, Scemblix will be indicated for adults with chronic myeloid leukemia (CML), both newly diagnosed and previously treated, expanding access to four times as many patients in EuropeScemblix ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
After Novartis (NVS) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive ...
Novartis (NVS) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has adopted a ...
PRESS RELEASE AB SCIENCE PROVIDES INITIAL PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ...
The Smithsonian’s portraits of women scientists give us a glimpse into the lives that helped shape modern discovery. Each ...
Sex cells made from scratch could revolutionize human reproduction. But researchers are struggling to translate promising ...
With the bull market starting its fourth year, and yields on U.S. debt falling to the lowest levels since early this year, ...
Depending on the setting, the ability of a crucial bacterium in biotechnology—Agrobacterium tumefaciens—to transfer its DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results